ImmuCell Revenue 2011-2025 | ICCC
ImmuCell revenue from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
ImmuCell Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $26 |
| 2023 | $17 |
| 2022 | $19 |
| 2021 | $19 |
| 2020 | $15 |
| 2019 | $14 |
| 2018 | $11 |
| 2017 | $10 |
| 2016 | $10 |
| 2015 | $10 |
| 2014 | $8 |
| 2013 | $6 |
| 2012 | $5 |
| 2011 | $5 |
| 2010 | $4 |
|
ImmuCell Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $6 |
| 2025-06-30 | $6 |
| 2025-03-31 | $8 |
| 2024-12-31 | $8 |
| 2024-09-30 | $6 |
| 2024-06-30 | $5 |
| 2024-03-31 | $7 |
| 2023-12-31 | $5 |
| 2023-09-30 | $5 |
| 2023-06-30 | $4 |
| 2023-03-31 | $3 |
| 2022-12-31 | $4 |
| 2022-09-30 | $5 |
| 2022-06-30 | $4 |
| 2022-03-31 | $6 |
| 2021-12-31 | $5 |
| 2021-09-30 | $5 |
| 2021-06-30 | $5 |
| 2021-03-31 | $4 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $3 |
| 2020-03-31 | $5 |
| 2019-12-31 | $4 |
| 2019-09-30 | $3 |
| 2019-06-30 | $3 |
| 2019-03-31 | $4 |
| 2018-12-31 | $3 |
| 2018-09-30 | $2 |
| 2018-06-30 | $3 |
| 2018-03-31 | $3 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $4 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $3 |
| 2015-12-31 | $3 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | $2 |
| 2014-06-30 | $2 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $2 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $2 |
| 2010-12-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.047B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.863B | 25.11 |
| EssilorLuxottica (ESLOY) | France | $167.089B | 0.00 |
| Boston Scientific (BSX) | United States | $146.124B | 33.41 |
| Stryker (SYK) | United States | $139.948B | 27.79 |
| Medtronic (MDT) | Ireland | $130.727B | 18.11 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.697B | 0.00 |
| Agilent Technologies (A) | United States | $42.315B | 26.75 |
| GE HealthCare Technologies (GEHC) | United States | $38.077B | 18.21 |
| ResMed (RMD) | United States | $36.695B | 25.40 |
| Koninklijke Philips (PHG) | Netherlands | $27.000B | 17.64 |
| Terumo (TRUMY) | Japan | $22.579B | 25.42 |
| Insulet (PODD) | United States | $21.636B | 67.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.987B | 0.00 |
| Baxter (BAX) | United States | $9.711B | 7.84 |
| Sunny Optical Technology (SNPTF) | China | $9.054B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.641B | 31.07 |
| Demant (WILYY) | Denmark | $6.756B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.963B | 12.07 |
| Haemonetics (HAE) | United States | $3.834B | 17.07 |
| ICU Medical (ICUI) | United States | $3.556B | 22.58 |
| Envista Holdings (NVST) | United States | $3.363B | 19.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.899B | 13.22 |
| LeMaitre Vascular (LMAT) | United States | $1.926B | 38.78 |
| Perrigo (PRGO) | Ireland | $1.921B | 4.81 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.02 |
| AtriCure (ATRC) | United States | $1.805B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.678B | 16.76 |
| Curaleaf Holdings (CURLF) | Canada | $1.655B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.370B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 58.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.328B | 0.00 |
| Neogen (NEOG) | United States | $1.291B | 24.75 |
| AdaptHealth (AHCO) | United States | $1.265B | 18.31 |
| BioLife Solutions (BLFS) | United States | $1.228B | 364.43 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.898B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.793B | 0.00 |
| Omeros (OMER) | United States | $0.753B | 0.00 |
| Valneva SE (VALN) | France | $0.744B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 13.02 |
| BillionToOne (BLLN) | $0.460B | 0.00 | |
| SNDL (SNDL) | Canada | $0.457B | 0.00 |
| Evolus (EOLS) | United States | $0.438B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.427B | 0.00 |
| Cerus (CERS) | United States | $0.382B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| Brainsway (BWAY) | Israel | $0.336B | 57.30 |
| Verano Holdings (VRNO) | United States | $0.323B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.291B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.290B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 151.33 |
| Viemed Healthcare (VMD) | United States | $0.257B | 20.49 |
| High Tide (HITI) | Canada | $0.232B | 0.00 |
| Organigram Global (OGI) | Canada | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.201B | 2.02 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.183B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 15.72 |
| Vireo Growth (VREOF) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.166B | 20.44 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.108B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 13.03 |
| MacroGenics (MGNX) | United States | $0.089B | 0.00 |
| Sharps Technology (STSS) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Nephros (NEPH) | United States | $0.057B | 41.54 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.036B | 0.00 |
| Veru (VERU) | United States | $0.035B | 0.00 |
| Zynex (ZYXI) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| United-Guardian (UG) | United States | $0.027B | 13.47 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.004B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |